Cargando…

Variation in Glycemic Outcomes in Focal Forms of Congenital Hyperinsulinism—The UK Perspective

CONTEXT: In focal congenital hyperinsulinism (CHI), localized clonal expansion of pancreatic β-cells causes excess insulin secretion and severe hypoglycemia. Surgery is curative, but not all lesions are amenable to surgery. OBJECTIVE: We describe surgical and nonsurgical outcomes of focal CHI in a n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dastamani, Antonia, Yau, Daphne, Gilbert, Clare, Morgan, Kate, De Coppi, Paolo, Craigie, Ross J, Bomanji, Jamshed, Biassoni, Lorenzo, Sajjan, Rakesh, Flanagan, Sarah E, Houghton, Jayne A L, Senniappan, Senthil, Didi, Mohammed, Dunne, Mark J, Banerjee, Indraneel, Shah, Pratik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113085/ https://www.ncbi.nlm.nih.gov/pubmed/35592516 http://dx.doi.org/10.1210/jendso/bvac033

Ejemplares similares

Case report: contradictory genetics and imaging in focal congenital hyperinsulinism reinforces the need for pancreatic biopsy
por: Yau, Daphne, et al.
Publicado: (2020)

Using referral rates for genetic testing to determine the incidence of a rare disease: The minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389
por: Yau, Daphne, et al.
Publicado: (2020)

Clinical Diversity in Focal Congenital Hyperinsulinism in Infancy Correlates With Histological Heterogeneity of Islet Cell Lesions
por: Craigie, Ross J., et al.
Publicado: (2018)

The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism
por: Worth, Chris, et al.
Publicado: (2022)

Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset
por: Worth, Chris, et al.
Publicado: (2022)

Unravelling the genetic causes of mosaic islet morphology in congenital hyperinsulinism
por: Houghton, Jayne AL, et al.
Publicado: (2019)

Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus
por: Shaikh, M. Guftar, et al.
Publicado: (2023)

(68)Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
por: Boss, Marti, et al.
Publicado: (2022)

Central venous catheter-associated thrombosis in children with congenital hyperinsulinism
por: Yau, Daphne, et al.
Publicado: (2019)

Spectrum of neuro-developmental disorders in children with congenital hyperinsulinism due to activating mutations in GLUD1
por: Aftab, Sommayya, et al.
Publicado: (2022)

Fluoxetine-Induced Hypoglycaemia in a Patient with Congenital Hyperinsulinism on Lanreotide Therapy
por: Giri, Dinesh, et al.
Publicado: (2016)

Congenital hyperinsulinism and Poland syndrome in association with 10p13–14 duplication
por: Giri, Dinesh, et al.
Publicado: (2017)

Continuous Flash Glucose Monitoring in children with Congenital Hyperinsulinism; first report on accuracy and patient experience
por: Alsaffar, Hussain, et al.
Publicado: (2018)

The molecular mechanisms, diagnosis and management of congenital hyperinsulinism
por: Senniappan, Senthil, et al.
Publicado: (2013)

Efficacy of Dose-Titrated Glucagon Infusions in the Management of Congenital Hyperinsulinism: A Case Series
por: Salomon-Estebanez, Maria, et al.
Publicado: (2020)

Familial Focal Congenital Hyperinsulinism
por: Ismail, Dunia, et al.
Publicado: (2011)

Corrigendum: Efficacy of Dose-Titrated Glucagon Infusions in the Management of Congenital Hyperinsulinism: A Case Series
por: Salomon-Estebanez, Maria, et al.
Publicado: (2020)

Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation
por: Kiff, Sarah, et al.
Publicado: (2019)

Pancreatic Endocrine and Exocrine Function in Children following Near-Total Pancreatectomy for Diffuse Congenital Hyperinsulinism
por: Arya, Ved Bhushan, et al.
Publicado: (2014)

Refinement of the critical genomic region for congenital hyperinsulinism in the Chromosome 9p deletion syndrome
por: Banerjee, Indraneel, et al.
Publicado: (2020)

Atypical Forms of Congenital Hyperinsulinism in Infancy Are Associated With Mosaic Patterns of Immature Islet Cells
por: Han, Bing, et al.
Publicado: (2017)

Feeding Problems Are Persistent in Children with Severe Congenital Hyperinsulinism
por: Banerjee, Indraneel, et al.
Publicado: (2016)

Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient
por: Banerjee, Indraneel, et al.
Publicado: (2017)

Congenital hyperinsulinism: diagnostic and management challenges in a developing country – case report
por: John, Cheri Mathews, et al.
Publicado: (2017)

Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11
por: Hewat, Thomas I., et al.
Publicado: (2021)

Increased referrals for congenital hyperinsulinism genetic testing in children with trisomy 21 reflects the high burden of non‐genetic risk factors in this group
por: Hewat, Thomas I., et al.
Publicado: (2022)

Non-coding variants disrupting a tissue-specific regulatory element in HK1 cause congenital hyperinsulinism
por: Wakeling, Matthew N., et al.
Publicado: (2022)

Heterozygous Insulin Receptor (INSR) Mutation Associated with Neonatal Hyperinsulinemic Hypoglycaemia and Familial Diabetes Mellitus: Case Series
por: Sethi, Aashish, et al.
Publicado: (2020)

Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital Hyperinsulinism
por: Avatapalle, Hima Bindu, et al.
Publicado: (2013)

Can network biology unravel the aetiology of congenital hyperinsulinism?
por: Stevens, Adam, et al.
Publicado: (2013)

Delayed Resolution of Feeding Problems in Patients With Congenital Hyperinsulinism
por: Worth, Chris, et al.
Publicado: (2020)

Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time
por: Salomon-Estebanez, Maria, et al.
Publicado: (2016)

Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the Disease
por: Han, Bing, et al.
Publicado: (2016)

Morphoproteomics and biomedical analytics coincide with clinical outcomes in supporting a constant but variable role for the mTOR pathway in the biology of congenital hyperinsulinism of infancy
por: Brown, Robert E., et al.
Publicado: (2017)

Molecular Characterization and Management of Congenital Hyperinsulinism: A Tertiary Centre Experience
por: Sharma, Rajni, et al.
Publicado: (2022)

Congenital Hyperinsulinism and Evolution to Sulfonylurearesponsive Diabetes Later in Life due to a Novel Homozygous p.L171F ABCC8 Mutation
por: Işık, Emregül, et al.
Publicado: (2019)

Clustering of Hypoglycemia Events in Patients With Hyperinsulinism: Extension of the Digital Phenotype Through Retrospective Data Analysis
por: Worth, Chris, et al.
Publicado: (2021)

Reduced Glycemic Variability in Diazoxide-Responsive Children with Congenital Hyperinsulinism Using Supplemental Omega-3-Polyunsaturated Fatty Acids; A Pilot Trial with MaxEPA(R)
por: Skae, Mars, et al.
Publicado: (2014)

Hyperinsulinism–hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype–phenotype correlations
por: Kapoor, Ritika R, et al.
Publicado: (2009)

Laparoscopic Surgery for Focal-Form Congenital Hyperinsulinism Located in Pancreatic Head
por: Wen, Zhe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ll8514d0qvbi6bhhe0nqfmbb6